Exercise and Risk of cardiovascular events in women with nonmetastatic breast cancer

Journal of Clinical Oncology

Volumn 34, Issue 23, 2016, Pages 2743-2749

  Jones, Lee W ^a   Habel, Laurel A ^b   Weltzien, Erin ^b   Castillo, Adrienne ^b   Gupta, Dipti ^a   Kroenke, Candyce H ^b   Kwan, Marilyn L ^b   Quesenberry, Charles P ^b   Scott, Jessica ^c   Sternfeld, Barbara ^b   Yu, Anthony ^a   Kushi, Lawrence H ^b   Caan, Bette J ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b KAISER PERMANENTE   (United States)

^c NASA JOHNSON SPACE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; AROMATASE INHIBITOR; DOXORUBICIN; TAMOXIFEN;

ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; EXERCISE; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART DEATH; HEART FAILURE; HUMAN; INCIDENCE; LEISURE; MAJOR CLINICAL STUDY; MENOPAUSE; METABOLIC EQUIVALENT; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PARTIAL MASTECTOMY; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PROGESTERONE RECEPTOR POSITIVE BREAST CANCER; PROSPECTIVE STUDY; RISK REDUCTION; TREND STUDY; VALVULAR HEART DISEASE; AGED; ARRHYTHMIAS, CARDIAC; BREAST NEOPLASMS; CARDIOVASCULAR DISEASES; HEART VALVE DISEASES; PATHOLOGY; PHYSIOLOGY; PROTECTION; PROTOCOL COMPLIANCE; QUESTIONNAIRE; REGISTER; RISK FACTOR; STROKE;

ADULT; AGED; ARRHYTHMIAS, CARDIAC; BREAST NEOPLASMS; CARDIOVASCULAR DISEASES; CORONARY ARTERY DISEASE; EXERCISE; FEMALE; FOLLOW-UP STUDIES; GUIDELINE ADHERENCE; HEART FAILURE; HEART VALVE DISEASES; HUMANS; INCIDENCE; METABOLIC EQUIVALENT; MIDDLE AGED; PROSPECTIVE STUDIES; PROTECTIVE FACTORS; REGISTRIES; RISK FACTORS; STROKE; SURVEYS AND QUESTIONNAIRES;

EID: 84981725643     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2015.65.6603     Document Type: Article

References (42)

1. Jatoi I, Chen BE, Anderson WF, et al: Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis. J Clin Oncol 25:1683-1690, 2007
2. Doyle JJ, Neugut AI, Jacobson JS, et al: Chemotherapy and cardiotoxicity in older breast cancer patients: A population-based study. J Clin Oncol 23:8597-8605, 2005
3. Chapman JA, Meng D, Shepherd L, et al: Competing causes of death from a randomized trial of extended adjuvant endocrine therapy for breast cancer. J Natl Cancer Inst 100:252-260, 2008
4. Hanrahan EO, Gonzalez-Angulo AM, Giordano SH, et al: Overall survival and cause-specific mortality of patients with stage T1a, bN0M0 breast carcinoma. J Clin Oncol 25:4952-4960, 2007
5. Patnaik JL, Byers T, DiGuiseppi C, et al: Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: A retrospective cohort study. Breast Cancer Res 13:R64, 2011
6. Hooning MJ, Botma A, Aleman BM, et al: Long-Term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst 99: 365-375, 2007
7. Moslehi J: The cardiovascular perils of cancer survivorship. N Engl J Med 368:1055-1056, 2013
8. Lichtman SM, Hurria A, Jacobsen PB: Geriatric oncology: An overview. J Clin Oncol 32:2521-2522, 2014
9. Jones LW, Haykowsky MJ, Swartz JJ, et al: Early breast cancer therapy and cardiovascular injury. J Am Coll Cardiol 50:1435-1441, 2007
10. Warburton DE, Nicol CW, Bredin SS: Health benefits of physical activity: The evidence. CMAJ 174:801-809, 2006
11. Kwan G, Balady GJ: Cardiac rehabilitation 2012: Advancing the field through emerging science. Circulation 125:e369-e373, 2012
12. Caan B, Sternfeld B, Gunderson E, et al: Life After Cancer Epidemiology (LACE) Study: A cohort of early stage breast cancer survivors (United States). Cancer Causes Control 16:545-556, 2005
13. Kwan ML, Ambrosone CB, Lee MM, et al: The Pathways study: A prospective study of breast cancer survivorship within Kaiser Permanente Northern California. Cancer Causes Control 19:1065-1076, 2008
14. Sternfeld B, Weltzien E, Quesenberry CP, Jr., et al: Physical activity and risk of recurrence and mortality in breast cancer survivors: Findings from the LACE study. Cancer Epidemiol Biomarkers Prev 18:87-95, 2009
15. Ainsworth BE, Haskell WL, Herrmann SD, et al: 2011 Compendium of Physical Activities: A second update of codes and MET values. Med Sci Sports Exerc 43:1575-1581, 2011
16. Groarke JD, Cheng S, Moslehi J: Cancer-drug discovery and cardiovascular surveillance. N Engl J Med 369:1779-1781, 2013
17. Breslow NE: Discussion of Professor Cox's paper. J Royal Stat Soc B 34:216-217, 1972
18. Lahart IM, Metsios GS, Nevill AM, et al: Physical activity, risk of death and recurrence in breast cancer survivors: A systematic review and meta-Analysis of epidemiological studies. Acta Oncol 54:635-654, 2015
19. Ballard-Barbash R, Friedenreich CM, Courneya KS, et al: Physical activity, biomarkers, and disease outcomes in cancer survivors: A systematic review. J Natl Cancer Inst 104:815-840, 2012
20. Yeh ET, Bickford CL: Cardiovascular complications of cancer therapy: Incidence, pathogenesis, diagnosis, and management. J Am Coll Cardiol 53: 2231-2247, 2009
21. Khouri MG, Douglas PS, Mackey JR, et al: Cancer therapy-induced cardiac toxicity in early breast cancer: Addressing the unresolved issues. Circulation 126:2749-2763, 2012
22. Zhang S, Liu X, Bawa-Khalfe T, et al: Identification of the molecular basis of doxorubicin-induced cardiotoxicity. Nat Med 18:1639-1642, 2012
23. Manson JE, Greenland P, LaCroix AZ, et al: Walking compared with vigorous exercise for the prevention of cardiovascular events in women. N Engl J Med 347:716-725, 2002
24. Manson JE, Hu FB, Rich-Edwards JW, et al: A prospective study of walking as compared with vigorous exercise in the prevention of coronary heart disease inwomen. N Engl JMed 341:650-658, 1999
25. Hu FB, Willett WC, Li T, et al: Adiposity as compared with physical activity in predicting mortality among women. N Engl J Med 351:2694-2703, 2004
26. Koelwyn GJ, Khouri M, Mackey JR, et al: Running on empty: Cardiovascular reserve capacity and late effects of therapy in cancer survivorship. J Clin Oncol 30:4458-4461, 2012
27. Slamon D, Eiermann W, Robert N, et al: Adjuvant trastuzumab in HER2-positive breast cancer. N Engl J Med 365:1273-1283, 2011
28. Hu FB, Stampfer MJ, Solomon C, et al: Physical activity and risk for cardiovascular events in diabetic women. Ann Intern Med 134:96-105, 2001
29. Zagar TM, Cardinale DM, Marks LB: Breast cancer therapy-Associated cardiovascular disease. Nat Rev Clin Oncol 13:172-184, 2016
30. Schmitz KH, Courneya KS, Matthews C, et al: American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 42:1409-1426, 2010
31. Sasso JP, Eves ND, Christensen JF, et al: A framework for prescription in exercise-oncology research. J Cachexia Sarcopenia Muscle 6:115-124, 2015
32. Jones LW, Eves ND, Peppercorn J: Preexercise screening and prescription guidelines for cancer patients. Lancet Oncol 11:914-916, 2010
33. Shephard RJ, Balady GJ: Exercise as cardiovascular therapy. Circulation 99:963-972, 1999
34. Franklin B, Bonzheim K, Warren J, et al: Effects of a contemporary, exercise-based rehabilitation and cardiovascular risk-reduction program on coronary patients with abnormal baseline risk factors. Chest 122:338-343, 2002
35. Alfano CM, Ganz PA, Rowland JH, et al: Cancer survivorship and cancer rehabilitation: Revitalizing the link. J Clin Oncol 30:904-906, 2012
36. Gulati M, Pandey DK, Arnsdorf MF, et al: Exercise capacity and the risk of death in women: The St James Women Take Heart Project. Circulation 108:1554-1559, 2003
37. Blair SN, Kampert JB, Kohl HW III, et al: Influences of cardiorespiratory fitness and other precursors on cardiovascular disease and all-cause mortality in men and women. JAMA 276:205-210, 1996
38. Fujimoto N, Prasad A, Hastings JL, et al: Cardiovascular effects of 1 year of progressive and vigorous exercise training in previously sedentary individuals older than 65 years of age. Circulation 122: 1797-1805, 2010
39. Ventura-Clapier R, Mettauer B, Bigard X: Beneficial effects of endurance training on cardiac and skeletal muscle energy metabolism in heart failure. Cardiovasc Res 73:10-18, 2007
40. Hambrecht R, Fiehn E, Weigl C, et al: Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation 98:2709-2715, 1998
41. Haykowsky MJ, Brubaker PH, Stewart KP, et al: Effect of endurance training on the determinants of peak exercise oxygen consumption in elderly patients with stable compensated heart failure and preserved ejection fraction. J Am Coll Cardiol 60:120-128, 2012
42. Scott JM, Koelwyn GJ, Hornsby WE, et al: Exercise therapy as treatment for cardiovascular and oncologic disease after a diagnosis of early-stage cancer. Semin Oncol 40:218-228, 2013